HLA-C and myeloid sarcoma: Genome-wide association studies (GWAS) have recently revealed genetic risk factors for MS (International Multiple Sclerosis Genetics Consortium [IMSGC], 2019) and confirmed 233 loci, including 201 non-MHC and 32 MHC variants.